1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer commun (London), 2019, 39(1): 22.
|
3. |
Shen L, Shan YS, Hu HM, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol, 2013, 14(12): e535-e547.
|
4. |
Rosa F, Alfieri S, Tortorelli AP, et al. Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1 278 patients over 30 years. World J Surg Oncol, 2014, 12: 217.
|
5. |
Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol, 2017, 14(9): 531-548.
|
6. |
Praharaj PP, Bhutia SK, Nagrath S, et al. Circulating tumor cell-derived organoids: current challenges and promises in medical research and precision medicine. Biochim Biophys Acta Rev Cancer, 2018, 1869(2): 117-127.
|
7. |
Li Y, Ma G, Zhao P, et al. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH. Clin Chim Acta, 2018, 485: 95-102.
|
8. |
Qin L, Zhou W, Zhang S, et al. Highly efficient isolation of circulating tumor cells using a simple wedge-shaped microfluidic device. IEEE Trans Biomed Eng, 2019, 66(6): 1536-1541.
|
9. |
Eyles J, Puaux AL, Wang X, et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest, 2010, 120(6): 2030-2039.
|
10. |
Zhang Q, Shan F, Li Z, et al. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer. J Transl Med, 2018, 16(1): 171.
|
11. |
Sun S, Yang S, Hu X, et al. Combination of immunomagnetic separation with aptamer-mediated double rolling circle amplification for highly sensitive circulating tumor cell detection. ACS Sens, 2020, 5(12): 3870-3878.
|
12. |
de Miguel-Pérez D, Bayarri-Lara CI, Ortega FG, et al. Post-surgery circulating tumor cells and axl overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma. Cancers (Basel), 2019, 11(11): 1750.
|
13. |
Normanno N, Cervantes A, Ciardiello F, et al. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios. Cancer Treat Rev, 2018, 70: 1-8.
|
14. |
郗洪庆, 张珂诚, 卫勃, 等. 胃癌 TNM 分期第八版更新在临床诊断治疗中的意义和思考. 中华胃肠外科杂志 , 2017, 20(2): 166-170.
|
15. |
中国研究型医院学会微创外科学专业委员会, 《腹腔镜外科杂志》. 循环肿瘤细胞检测在结直肠癌中的应用专家共识(2018). 腹腔镜外科杂志, 2019, 24(1): 74-80.
|
16. |
Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res, 2004, 10(20): 6897-6904.
|
17. |
Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells—mechanisms of immune surveillance and escape. Nat Rev Clin Oncol, 2017, 14(3): 155-167.
|
18. |
Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell, 2013, 23(5): 573-581.
|
19. |
Hu B, Tian X, Li Y, et al. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1. Cancer Med, 2020, 9(8): 2686-2697.
|
20. |
Wu S, Liu S, Liu Z, et al. Classification of circulating tumor cells by epithelial-mesenchymal transition markers. PLoS One, 2015, 10(4): e0123976.
|
21. |
Li TT, Liu H, Li FP, et al. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: relevance to therapy response. World J Gastroenterol, 2015, 21(47): 13259-13267.
|
22. |
Sun W, Huang T, Li G, et al. The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer. Future Oncol, 2013, 9(10): 1489-1500.
|
23. |
Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer, 2004, 4(6): 448-456.
|
24. |
Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 2007, 25(33): 5287-5312.
|
25. |
唐林, 陈巍魏, 管晓翔. AJCC第8版乳腺癌分期系统更新的解读. 临床肿瘤学杂志, 2017, 22(11): 1038-1040.
|
26. |
郭迎雪, 李贵新, 李方超, 等. 胃癌中循环肿瘤细胞与临床特征的关系. 潍坊医学院学报, 2016, 38(1): 73-75.
|
27. |
朱莹, 易善永, 郭云霞, 等. HER-2阴性晚期胃癌外周血循环肿瘤细胞检测及临床意义. 中国肿瘤外科杂志, 2018, 10(3): 153-155.
|
28. |
Uenosono Y, Arigami T, Kozono T, et al. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer. Cancer, 2013, 119(22): 3984-3991.
|
29. |
Lee SJ, Lee J, Kim ST, et al. Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer. Int J Biol Markers, 2015, 30(4): e382-e386.
|
30. |
Okabe H, Tsunoda S, Hosogi H, et al. Circulating tumor cells as an independent predictor of survival in advanced gastric cancer. Ann Surg Oncol, 2015, 22(12): 3954-3961.
|
31. |
Cao W, Yang W, Li H, et al. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. J Surg Oncol, 2011, 103(2): 110-115.
|
32. |
Cheng B, Tong G, Wu X, et al. Enumeration and characterization of circulating tumor cells and its application in advanced gastric cancer. Onco Targets Ther, 2019, 12: 7887-7896.
|
33. |
Abdallah EA, Braun AC, Flores BCTCP, et al. The potential clinical implications of circulating tumor cells and circulating tumor microemboli in gastric cancer. Oncologist, 2019, 24(9): e854-e863.
|
34. |
Pernot S, Badoual C, Terme M, et al. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: prognostic value and early assessment of therapeutic effects. Eur J Cancer, 2017, 79: 15-22.
|
35. |
Thanh Huong P, Gurshaney S, Thanh Binh N, et al. Emerging role of circulating tumor cells in gastric cancer. Cancers (Basel), 2020, 12(3): 695.
|
36. |
Li M, Zhang B, Zhang Z, et al. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int, 2014, 2014: 981261.
|